Evidence map›Paper›PMID 33946907›Full record

ArticleMolecules (Basel, Switzerland)2021

Identification of New Potential Inhibitors of Quorum Sensing through a Specialized Multi-Level Computational Approach.

Fábio G Martins, André Melo, Sérgio F Sousa

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Biofilm · 2024
    Article
  4. Antibiotics (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Drug Repurposing TargetingAntibiotics (Basel, Switzerland) · 2022
    Article
  10. RepurposingAntibiotics (Basel, Switzerland) · 2022
    Article
  11. Computational and Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fábio G MartinsUCIBIO/REQUIMTE, BioSIM-Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal.ORCID 0000-0001-6257-8885
André MeloLAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade do Porto, 4169-007 Porto, Portugal.
Sérgio F SousaUCIBIO/REQUIMTE, BioSIM-Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal.

Funding

Fundação para a Ciência e a Tecnologia UIDP/04378/2020, UIDB/04378/2020, IF/00052/2014, UID/QUI/50006/2019, and 2020.01423.CEECIND
6 · The paper itself

Abstract

Biofilms are aggregates of microorganisms anchored to a surface and embedded in a self-produced matrix of extracellular polymeric substances and have been associated with 80% of all bacterial infections in humans. Because bacteria in biofilms are less amenable to antibiotic treatment, biofilms have been associated with developing antibiotic resistance, a problem that urges developing new therapeutic options and approaches. Interfering with quorum-sensing (QS), an important process of cell-to-cell communication by bacteria in biofilms is a promising strategy to inhibit biofilm formation and development. Here we describe and apply an in silico computational protocol for identifying novel potential inhibitors of quorum-sensing, using CviR-the quorum-sensing receptor from

Indexed as

Drug DiscoveryModels, MolecularAnti-Bacterial AgentsBacterial ProteinsBinding SitesBiofilmsHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureProtein BindingQuorum SensingStructure-Activity RelationshipAnti-Bacterial AgentsBacterial ProteinsLigandsbiofilmsChromobacterium violaceumCviRMM/GBSAMM/PBSAmolecular dockingmolecular dynamics simulationsquorum-sensingvirtual screening

Identifiers

PMID33946907
PMCPMC8125606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.